Phio pharmaceuticals fintel

WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology makes immune cells more effective in … WebbPHIO / Phio Pharmaceuticals Corp off-exchange short sale volume is shown in the following chart. Short Sale volume shows the number of trades marked as short sales in …

PHIO - Phio Pharmaceuticals Corp. Stock Price and Quote

WebbResumen PHIO Gráfico técnico Phio Pharmaceuticals Corp 5,527 + 0,259 ( + 4,92 %) S 1 semana 1 año Máx. Último cierre 5,268 Rango día 5,321 - 6 Ingresos - Apertura 5,321 52 semanas 3,9 - 29,04... Webb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to make immune cells more effective in killing tumor cells. Corporate Presentation The following is an investor update, effective January 2024, presented by Robert Bitterman. Mr. philip and kelvin laverne coffee table value https://robertsbrothersllc.com

PHIO / Phio Pharmaceuticals Corp - Net Long/Short Value

WebbPHIO Short Sale Transactions - Phio Pharmaceuticals Corp EXTENDED. Day's Range - 52 Week Range - WebbPhio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update. Additional Formats PDF Version. February 22, 2024 Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer. Additional Formats PDF Version. February 13, 2024 ... WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAI technology makes immune cells more effective in killing tumor cells. INTASYL is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. philip and james

Phio Pharmaceuticals About Us

Category:Investor Relations - Phio Pharmaceuticals

Tags:Phio pharmaceuticals fintel

Phio pharmaceuticals fintel

PHIO Phio Pharmaceuticals Corp - Stocktwits

Webb6 apr. 2024 · Phio Pharmaceuticals (NASDAQ:PHIO) has a recorded net income of -$11.48 million. PHIO has generated -$10.68 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts … WebbPhio Pharmaceuticals stock is traded on Nasdaq as PHIO. The firm is headquartered in Marlborough, Ma. in Middlesex County. The firm's Chairman is Robert Bitterman, …

Phio pharmaceuticals fintel

Did you know?

Webb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical-stage biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™)... Webb10 apr. 2024 · Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. About the company Risk Analysis Earnings have declined by 8.5% per year over past 5 years Has less than 1 year of cash runway Makes less than USD$1m in revenue ($0) Does not have a meaningful market cap ($7M) + 2 more risks See All Risk Checks …

WebbPhio Pharmaceuticals Our Science Our Science Overview Phio is addressing some of the biggest challenges in immuno-oncology (I/O) by developing therapeutics that leverage … WebbAt Phio Pharmaceuticals, our mission is to develop innovative cancer treatments that overcome tumor immunosuppression and weaponize the immune system against …

WebbPhio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough, MA 01752 (508) 767-3861 February 7, 2024 VIA EDGAR Securities and Exchange Commission Division of … WebbPHIO Stock Financial Analysis - Phio Pharmaceuticals Corp (NASDAQ) Stock. Fintel ...

Webb30 mars 2024 · Phio Pharmaceuticals - PHIO News Today $5.99 +0.16 (+2.74%) (As of 03/30/2024 10:41 AM ET) Compare Today's Range $5.75 $5.99 50-Day Range $0.51 $6.85 52-Week Range $3.90 $29.04 Volume 1,039 shs Average Volume 36,447 shs Market Capitalization $6.89 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile …

Webb1 mars 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic... philip and lidia youtubeWebbPHIO Institutional Ownership, Sellers - Phio Pharmaceuticals Corp. Fintel ... philip and leaWebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly Draw Fullscreen Settings PHIO - Stock Price Chart PHIO [NASD] philip and lorna sarrellsWebb2024-11-14 - BlackRock Inc. has filed a 13F-HR form disclosing ownership of 19 shares of Phio Pharmaceuticals Corp (US:PHIO) with total holdings valued at $0 USD as of 2024 … philip and lillianphilipandlindsay.minted.usWebb8 apr. 2024 · MARLBOROUGH, Mass., April 8, 2024 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO ), a clinical stage biotechnology company developing the next generation of therapeutics based on... philip and margaretWebb359 rader · Phio Pharmaceuticals Corp insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is … philip and lukas movie